Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3 β/TTBK pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model
This study confirmed that pramlintide and liraglutide are promising antidiabetic medications that could prevent associated cognitive disorders in different mechanisms.PMID:38536493 | DOI:10.1007/s00424-024-02933-0
Source: Pflugers Archiv : European Journal of Physiology - Category: Physiology Authors: Hoda M Moghazy Nesreen G Abdelhaliem Sherine Ahmed Mohammed Asmaa Hassan Amany Abdelrahman Source Type: research
More News: Brain | Diabetes | Diabetes Type 2 | Diets | Endocrinology | High Fat | Neurology | Nutrition | Physiology | Study | Victoza